Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries
Peripheral nerve injuries (PNIs) are the term used to describe injuries that occur to the nerve fibers of the peripheral nervous system (PNS). Such injuries may be caused by trauma, infection, or aberrant immunological response. Although the peripheral nervous system has a limited capacity for self-...
Gespeichert in:
Veröffentlicht in: | Neurochemical research 2024-08, Vol.49 (8), p.1905-1925 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1925 |
---|---|
container_issue | 8 |
container_start_page | 1905 |
container_title | Neurochemical research |
container_volume | 49 |
creator | Rahimian, Sana Najafi, Hossein Webber, Christine A. Jalali, Hanieh |
description | Peripheral nerve injuries (PNIs) are the term used to describe injuries that occur to the nerve fibers of the peripheral nervous system (PNS). Such injuries may be caused by trauma, infection, or aberrant immunological response. Although the peripheral nervous system has a limited capacity for self-repair, in cases of severe damage, this process is either interrupted entirely or is only partially completed. The evaluation of variables that promote the repair of peripheral nerves has consistently been a focal point. Exosomes are a subtype of extracellular vesicles that originate from cellular sources and possess abundant proteins, lipids, and nucleic acids, play a critical role in facilitating intercellular communication. Due to their modifiable composition, they possess exceptional capabilities as carriers for therapeutic compounds, including but not limited to mRNAs or microRNAs. Exosome-based therapies have gained significant attention in the treatment of several nervous system diseases due to their advantageous properties, such as low toxicity, high stability, and limited immune system activation. The objective of this review article is to provide an overview of exosome-based treatments that have been developed in recent years for a range of PNIs, including nerve trauma, diabetic neuropathy, amyotrophic lateral sclerosis (ALS), glaucoma, and Guillain-Barre syndrome (GBS). It was concluded that exosomes could provide favorable results in the improvement of peripheral PNIs by facilitating the transfer of regenerative factors. The development of bioengineered exosome therapy for PNIs should be given more attention to enhance the efficacy of exosome treatment for PNIs.
Graphical Abstract
Inspired by the positive effects of exosomes on peripheral nerve regeneration, the figure illustrates the rejuvenating effect of exosomes on the peripheral nervous system |
doi_str_mv | 10.1007/s11064-024-04157-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3061785460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3077571265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-45fb5b49824c0258fb881c4fe9858fb3fe8c77cc4234e9b25c59b91ea19ed6af3</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMozvj4Ay4k4MZNNc8mXergC0RFdB3S9MbpMNPWZDrovzdjfYALF-EmnO-cGw5CB5ScUELUaaSU5CIjLB1BpcroBhqnybO8IHwTjQlPMqcFGaGdGGeEJBuj22jEtSYqXcfo_qxa2cZBxHWDL97a2C4gO7cRKvw0hWC7Okm-DXg5BfwIna0Dbj1-gFB3a32O7yCsAN80sz4kdg9teTuPsP81d9Hz5cXT5Dq7vb-6mZzdZo6zfJkJ6UtZikIz4QiT2pdaUyc8FHr94B60U8o5wbiAomTSyaIsKFhaQJVbz3fR8ZDbhfa1h7g0izo6mM9tA20fDSc5VVqKnCT06A86a_vQpN8lSimpKMtlothAudDGGMCbLtQLG94NJWZdtxnqNqlu81m3ocl0-BXdlwuofizf_SaAD0BMUvMC4Xf3P7EfgOmJXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3077571265</pqid></control><display><type>article</type><title>Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries</title><source>Springer Nature - Complete Springer Journals</source><creator>Rahimian, Sana ; Najafi, Hossein ; Webber, Christine A. ; Jalali, Hanieh</creator><creatorcontrib>Rahimian, Sana ; Najafi, Hossein ; Webber, Christine A. ; Jalali, Hanieh</creatorcontrib><description>Peripheral nerve injuries (PNIs) are the term used to describe injuries that occur to the nerve fibers of the peripheral nervous system (PNS). Such injuries may be caused by trauma, infection, or aberrant immunological response. Although the peripheral nervous system has a limited capacity for self-repair, in cases of severe damage, this process is either interrupted entirely or is only partially completed. The evaluation of variables that promote the repair of peripheral nerves has consistently been a focal point. Exosomes are a subtype of extracellular vesicles that originate from cellular sources and possess abundant proteins, lipids, and nucleic acids, play a critical role in facilitating intercellular communication. Due to their modifiable composition, they possess exceptional capabilities as carriers for therapeutic compounds, including but not limited to mRNAs or microRNAs. Exosome-based therapies have gained significant attention in the treatment of several nervous system diseases due to their advantageous properties, such as low toxicity, high stability, and limited immune system activation. The objective of this review article is to provide an overview of exosome-based treatments that have been developed in recent years for a range of PNIs, including nerve trauma, diabetic neuropathy, amyotrophic lateral sclerosis (ALS), glaucoma, and Guillain-Barre syndrome (GBS). It was concluded that exosomes could provide favorable results in the improvement of peripheral PNIs by facilitating the transfer of regenerative factors. The development of bioengineered exosome therapy for PNIs should be given more attention to enhance the efficacy of exosome treatment for PNIs.
Graphical Abstract
Inspired by the positive effects of exosomes on peripheral nerve regeneration, the figure illustrates the rejuvenating effect of exosomes on the peripheral nervous system</description><identifier>ISSN: 0364-3190</identifier><identifier>ISSN: 1573-6903</identifier><identifier>EISSN: 1573-6903</identifier><identifier>DOI: 10.1007/s11064-024-04157-1</identifier><identifier>PMID: 38807021</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Amyotrophic lateral sclerosis ; Biochemistry ; Bioengineering ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Cell interactions ; Damage assessment ; Diabetes mellitus ; Diabetic neuropathy ; Exosomes ; Fibers ; Glaucoma ; Guillain-Barre syndrome ; Health services ; Immune response ; Immune system ; Immunology ; Injuries ; Injury prevention ; Lipids ; miRNA ; Nervous system ; Nervous system diseases ; Neurochemistry ; Neurology ; Neurosciences ; Nucleic acids ; Peripheral nerves ; Peripheral nervous system ; Peripheral neuropathy ; Pharmaceuticals ; Pharmacology ; Review ; Toxic diseases ; Toxicity ; Trauma</subject><ispartof>Neurochemical research, 2024-08, Vol.49 (8), p.1905-1925</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-45fb5b49824c0258fb881c4fe9858fb3fe8c77cc4234e9b25c59b91ea19ed6af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11064-024-04157-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11064-024-04157-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38807021$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahimian, Sana</creatorcontrib><creatorcontrib>Najafi, Hossein</creatorcontrib><creatorcontrib>Webber, Christine A.</creatorcontrib><creatorcontrib>Jalali, Hanieh</creatorcontrib><title>Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries</title><title>Neurochemical research</title><addtitle>Neurochem Res</addtitle><addtitle>Neurochem Res</addtitle><description>Peripheral nerve injuries (PNIs) are the term used to describe injuries that occur to the nerve fibers of the peripheral nervous system (PNS). Such injuries may be caused by trauma, infection, or aberrant immunological response. Although the peripheral nervous system has a limited capacity for self-repair, in cases of severe damage, this process is either interrupted entirely or is only partially completed. The evaluation of variables that promote the repair of peripheral nerves has consistently been a focal point. Exosomes are a subtype of extracellular vesicles that originate from cellular sources and possess abundant proteins, lipids, and nucleic acids, play a critical role in facilitating intercellular communication. Due to their modifiable composition, they possess exceptional capabilities as carriers for therapeutic compounds, including but not limited to mRNAs or microRNAs. Exosome-based therapies have gained significant attention in the treatment of several nervous system diseases due to their advantageous properties, such as low toxicity, high stability, and limited immune system activation. The objective of this review article is to provide an overview of exosome-based treatments that have been developed in recent years for a range of PNIs, including nerve trauma, diabetic neuropathy, amyotrophic lateral sclerosis (ALS), glaucoma, and Guillain-Barre syndrome (GBS). It was concluded that exosomes could provide favorable results in the improvement of peripheral PNIs by facilitating the transfer of regenerative factors. The development of bioengineered exosome therapy for PNIs should be given more attention to enhance the efficacy of exosome treatment for PNIs.
Graphical Abstract
Inspired by the positive effects of exosomes on peripheral nerve regeneration, the figure illustrates the rejuvenating effect of exosomes on the peripheral nervous system</description><subject>Amyotrophic lateral sclerosis</subject><subject>Biochemistry</subject><subject>Bioengineering</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Cell interactions</subject><subject>Damage assessment</subject><subject>Diabetes mellitus</subject><subject>Diabetic neuropathy</subject><subject>Exosomes</subject><subject>Fibers</subject><subject>Glaucoma</subject><subject>Guillain-Barre syndrome</subject><subject>Health services</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunology</subject><subject>Injuries</subject><subject>Injury prevention</subject><subject>Lipids</subject><subject>miRNA</subject><subject>Nervous system</subject><subject>Nervous system diseases</subject><subject>Neurochemistry</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Nucleic acids</subject><subject>Peripheral nerves</subject><subject>Peripheral nervous system</subject><subject>Peripheral neuropathy</subject><subject>Pharmaceuticals</subject><subject>Pharmacology</subject><subject>Review</subject><subject>Toxic diseases</subject><subject>Toxicity</subject><subject>Trauma</subject><issn>0364-3190</issn><issn>1573-6903</issn><issn>1573-6903</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLxDAUhYMozvj4Ay4k4MZNNc8mXergC0RFdB3S9MbpMNPWZDrovzdjfYALF-EmnO-cGw5CB5ScUELUaaSU5CIjLB1BpcroBhqnybO8IHwTjQlPMqcFGaGdGGeEJBuj22jEtSYqXcfo_qxa2cZBxHWDL97a2C4gO7cRKvw0hWC7Okm-DXg5BfwIna0Dbj1-gFB3a32O7yCsAN80sz4kdg9teTuPsP81d9Hz5cXT5Dq7vb-6mZzdZo6zfJkJ6UtZikIz4QiT2pdaUyc8FHr94B60U8o5wbiAomTSyaIsKFhaQJVbz3fR8ZDbhfa1h7g0izo6mM9tA20fDSc5VVqKnCT06A86a_vQpN8lSimpKMtlothAudDGGMCbLtQLG94NJWZdtxnqNqlu81m3ocl0-BXdlwuofizf_SaAD0BMUvMC4Xf3P7EfgOmJXA</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Rahimian, Sana</creator><creator>Najafi, Hossein</creator><creator>Webber, Christine A.</creator><creator>Jalali, Hanieh</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20240801</creationdate><title>Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries</title><author>Rahimian, Sana ; Najafi, Hossein ; Webber, Christine A. ; Jalali, Hanieh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-45fb5b49824c0258fb881c4fe9858fb3fe8c77cc4234e9b25c59b91ea19ed6af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amyotrophic lateral sclerosis</topic><topic>Biochemistry</topic><topic>Bioengineering</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Cell interactions</topic><topic>Damage assessment</topic><topic>Diabetes mellitus</topic><topic>Diabetic neuropathy</topic><topic>Exosomes</topic><topic>Fibers</topic><topic>Glaucoma</topic><topic>Guillain-Barre syndrome</topic><topic>Health services</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunology</topic><topic>Injuries</topic><topic>Injury prevention</topic><topic>Lipids</topic><topic>miRNA</topic><topic>Nervous system</topic><topic>Nervous system diseases</topic><topic>Neurochemistry</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Nucleic acids</topic><topic>Peripheral nerves</topic><topic>Peripheral nervous system</topic><topic>Peripheral neuropathy</topic><topic>Pharmaceuticals</topic><topic>Pharmacology</topic><topic>Review</topic><topic>Toxic diseases</topic><topic>Toxicity</topic><topic>Trauma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahimian, Sana</creatorcontrib><creatorcontrib>Najafi, Hossein</creatorcontrib><creatorcontrib>Webber, Christine A.</creatorcontrib><creatorcontrib>Jalali, Hanieh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neurochemical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahimian, Sana</au><au>Najafi, Hossein</au><au>Webber, Christine A.</au><au>Jalali, Hanieh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries</atitle><jtitle>Neurochemical research</jtitle><stitle>Neurochem Res</stitle><addtitle>Neurochem Res</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>49</volume><issue>8</issue><spage>1905</spage><epage>1925</epage><pages>1905-1925</pages><issn>0364-3190</issn><issn>1573-6903</issn><eissn>1573-6903</eissn><abstract>Peripheral nerve injuries (PNIs) are the term used to describe injuries that occur to the nerve fibers of the peripheral nervous system (PNS). Such injuries may be caused by trauma, infection, or aberrant immunological response. Although the peripheral nervous system has a limited capacity for self-repair, in cases of severe damage, this process is either interrupted entirely or is only partially completed. The evaluation of variables that promote the repair of peripheral nerves has consistently been a focal point. Exosomes are a subtype of extracellular vesicles that originate from cellular sources and possess abundant proteins, lipids, and nucleic acids, play a critical role in facilitating intercellular communication. Due to their modifiable composition, they possess exceptional capabilities as carriers for therapeutic compounds, including but not limited to mRNAs or microRNAs. Exosome-based therapies have gained significant attention in the treatment of several nervous system diseases due to their advantageous properties, such as low toxicity, high stability, and limited immune system activation. The objective of this review article is to provide an overview of exosome-based treatments that have been developed in recent years for a range of PNIs, including nerve trauma, diabetic neuropathy, amyotrophic lateral sclerosis (ALS), glaucoma, and Guillain-Barre syndrome (GBS). It was concluded that exosomes could provide favorable results in the improvement of peripheral PNIs by facilitating the transfer of regenerative factors. The development of bioengineered exosome therapy for PNIs should be given more attention to enhance the efficacy of exosome treatment for PNIs.
Graphical Abstract
Inspired by the positive effects of exosomes on peripheral nerve regeneration, the figure illustrates the rejuvenating effect of exosomes on the peripheral nervous system</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38807021</pmid><doi>10.1007/s11064-024-04157-1</doi><tpages>21</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-3190 |
ispartof | Neurochemical research, 2024-08, Vol.49 (8), p.1905-1925 |
issn | 0364-3190 1573-6903 1573-6903 |
language | eng |
recordid | cdi_proquest_miscellaneous_3061785460 |
source | Springer Nature - Complete Springer Journals |
subjects | Amyotrophic lateral sclerosis Biochemistry Bioengineering Biomedical and Life Sciences Biomedicine Cell Biology Cell interactions Damage assessment Diabetes mellitus Diabetic neuropathy Exosomes Fibers Glaucoma Guillain-Barre syndrome Health services Immune response Immune system Immunology Injuries Injury prevention Lipids miRNA Nervous system Nervous system diseases Neurochemistry Neurology Neurosciences Nucleic acids Peripheral nerves Peripheral nervous system Peripheral neuropathy Pharmaceuticals Pharmacology Review Toxic diseases Toxicity Trauma |
title | Advances in Exosome-Based Therapies for the Repair of Peripheral Nerve Injuries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A41%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20Exosome-Based%20Therapies%20for%20the%20Repair%20of%20Peripheral%20Nerve%20Injuries&rft.jtitle=Neurochemical%20research&rft.au=Rahimian,%20Sana&rft.date=2024-08-01&rft.volume=49&rft.issue=8&rft.spage=1905&rft.epage=1925&rft.pages=1905-1925&rft.issn=0364-3190&rft.eissn=1573-6903&rft_id=info:doi/10.1007/s11064-024-04157-1&rft_dat=%3Cproquest_cross%3E3077571265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3077571265&rft_id=info:pmid/38807021&rfr_iscdi=true |